Skip to content
GLP-1 Savers

Head-to-head · Value Score

Eden vs Embody

Two GLP-1 deals, scored on the same six factors. Eden lands a Value Score of 91, Embody a 85. Compare their advertised prices, billing terms, and what to check before paying.

By Grant Ashford, Founder & Pricing Editor
★ Better value

Eden

Grade A · Excellent

Advertised price

$99/mo

$99/mo (compounded semaglutide injection)

Save ~72% vs brand self-pay
Get this deal Full Eden review →
VS

Embody

Grade A- · Great Deal

Advertised price

$79/mo month-to-month

$79/mo month-to-month ($49/mo on the 12-month bundle, all doses, compounded)

Get this deal Full Embody review →

The verdict

Better value: Eden

Eden takes it on Value Score, 91 to 85 — at an advertised price of $99/mo (compounded semaglutide injection). We found no advertised teaser step-up. Embody isn't out of it: Shoppers who want one compounded price at every dose, published as a full ladder from month-to-month to a 12-month bundle.

Featured partner:CoreAge Rx, advertised prices with checkout conditions (Value Score 81).Read the review →

If neither program settles it, the bmiMD review and the Wellorithm review cover two other programs we partner with, and each sets out its price and billing terms so you can run the same comparison.

Deal-by-deal

The numbers that decide it. Green ✓ marks the stronger side on each line.

DealEdenEmbody
Value Score91 (A)85 (A-)
Advertised price$99/mo (compounded semaglutide injection)$79/mo month-to-month ($49/mo on the 12-month bundle, all doses, compounded)
Save vs brand self-pay~72%—
Semaglutide$99/mo$79/mo month-to-month ($49/mo on the 12-month bundle, all doses, compounded)
Tirzepatide$129/mo$129/mo month-to-month ($99/mo on the 12-month bundle, all doses, compounded)
Both moleculesYesYes
PricingFlat — no step-upWatch
CoverageAll 50 statesAll 50 states

Factor by factor

The six factors behind each Value Score. The orange bar marks the stronger side. See the methodology.

Lowest Real Price
Eden: 90. Embody: 90.
No Teaser-Rate Bait
Eden: 92. Embody: 80.
Nationwide Availability
Eden: 98. Embody: 96.
Both Molecules
Eden: 90. Embody: 98.
Easy Cancellation
Eden: 88. Embody: 62.
Reputation
Eden: 90. Embody: 68.

Eden

Eden’s current compounded injection plans advertise $99 monthly semaglutide and $129 tirzepatide including care, but its older offers and warranty terms still need clarification before you pay.

Why it's a deal

  • Eden’s current GLP-1 pages include provider review, clinical support, 24/7 messaging, dosing and side-effect guidance, priority delivery and a member community in the monthly price. No insurance is required, and the offer is marked HSA/FSA eligible; those inclusions help make the advertised $99 and $129 useful starting points for a household budget.
  • Eden says the starting price remains protected while your account stays active, including permitted pauses. Closing the account and returning later means accepting the price then available, so a pause and a permanent cancellation have different consequences for anyone hoping to preserve today’s rate.
  • Eden identifies Dr. Rebecca Emch as its VP of Pharmacy Operations, Dr. Halland Chen as Chief Medical Innovation Officer and Savannah King as an Eden Pharmacy pharmacist. Naming the people responsible for pharmacy operations and clinical development gives you something concrete to evaluate beyond a generic promise of doctor-guided care.
  • Eden’s about page names GoGoMeds, Precision, Enovex and AbsolutePharmacy and publishes their locations; its current product FAQ says prescriptions may come from Eden Pharmacy or vetted U.S. partners. The company also states its pharmacy and provider network serves all 50 states and Washington, D.C., though that does not guarantee eligibility for every individual treatment.
  • Eden’s separate refund policy provides a prorated refund for prepaid medication that cannot be supplied, calculated from the unshipped portion. It also offers an alternative treatment and says approved refunds are processed within 30 days; this gives readers a stated remedy for supply interruptions rather than an assumption that prepaid funds disappear.

The fine print

  • Eden’s product pages advertise a warranty for losing at least 15% in six months, but its terms describe a 10% threshold after 26 consecutive weekly doses and limit refunds to eligible membership fees. For a plan advertised without membership fees, the refund amount needs written clarification.
  • Eden’s guarantee terms require weekly check-ins, weekly posts in its private Facebook group and verification videos, including an initial video within 15 days. The refund promise is conditional on documented participation, so readers uncomfortable with those requirements should not count it as automatic protection.
  • Eden allows portal cancellation, but orders already sent to the pharmacy may continue. General subscription terms require cancellation before billing; the separate membership program requires 48 hours’ notice, and processed prescription charges are generally nonrefundable, so cancel before an order advances rather than waiting for shipment.
  • Eden’s older branded-treatment and GLP-1 pages still show a $39 introductory membership that renews at $99 monthly. Those pages do not establish the checkout total for the current $99/$129 injection offer; ask support to identify the applicable program and recurring charge instead of combining incompatible prices.
  • Eden’s lifetime-price headline sits alongside terms reserving price changes and excluding introductory promotions from its same-dose offer. I would keep the enrollment price and written renewal terms rather than assume every discount receives the lifetime protection described in the current FAQ.
  • FDA issued a June 2026 warning letter to Eden about misleading compounded-drug labeling and pharmacy claims. Eden’s current pages disclose that compounded medications are not FDA-approved, but branding and quality-control promises do not substitute for FDA review of the dispensed product.

Embody

Embody offers compounded semaglutide and tirzepatide via injection plus a unique compounded oral tirzepatide gum formulation.

What's good

  • Among the lowest compounded prices tracked here, and the same at every dose: $79 a month for semaglutide and $129 for tirzepatide billed monthly, per Embody's own terms
  • Unique compounded oral tirzepatide gum formulation — alternative for patients who prefer not to inject
  • Available in all 50 states with no insurance friction
  • 24/7 unlimited clinician messaging and dose-adjustment support included
  • Medical leadership by Dr. Alan Viglione, board-certified in Internal Medicine

The fine print

  • The $49 and $99 homepage headlines are 12-month bundle rates; billed monthly the same products are $79 and $129, and a 'save $200' sale banner sits beside them
  • Compounded only — no FDA-approved brand-name Ozempic, Wegovy, Zepbound, or Mounjaro option
  • Pharmacy partners not publicly named — compounding source transparency is limited
  • Compounded oral tirzepatide does not have an FDA-approved counterpart, and oral GLP-1 bioavailability remains an active area of clinical debate
Get the Eden deal Get the Embody deal

We earn a commission when you start treatment through some links on this site, at no extra cost to you. It never changes a Value Score.

Neither one the right fit? Every program that outscores Eden is ranked on the Eden alternatives ranking, and the same list for the other side is on alternatives to Embody.

More head-to-heads

The programs scoring closest to this pair, side by side.

← All comparisons

Prices, states and verification reflect each program's public disclosures at last check; the Value Score is our editorial judgment per the methodology. "% vs brand-name self-pay" compares a program's lowest disclosed monthly price against $349/mo, Wegovy's self-pay price at NovoCare Pharmacy, every standard dose after the two-month intro offer (checked October 2026). Prices change — confirm on each provider's site. Not medical advice; see our disclosure.